GlobalData, Sep 2011, Pages: 20
AmylinPharmaceuticals, Inc. (AMLN) - Product Pipeline Analysis
Summary
AmylinPharmaceuticals, Inc. (AmylinPharmaceuticals) is a biopharmaceutical company principally engaged in discovery
Global Markets Direct, Dec 2010, Pages: 70
Mechanism of Action
R&D Progress
AmylinPharmaceuticals, Inc. – Pipeline AnalysisAmylinPharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
AmylinPharmaceuticals, Inc. Pipeline
Wright Investors' Service, Feb 2012, Pages: 51
, examines the liquidity of the stock, financial strength, profitability and corporate growth characteristics of AmylinPharmaceuticals, Inc.. There is a textual review of the financial results of Amylin
Life Science Analytics, March 2011, Pages: 150
AmylinPharmaceuticals, Inc-Therapeutic Competitors Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company
Plimsoll Publishing Ltd., Feb 2012, Pages: 560
HUADONG MEDICINE CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES LIMITED
AMYLINPHARMACEUTICALSINC
YUNNAN BAIYAO GROUP CO., LTD.
MAX INDIA LIMITED
ELAN CORPORATION PUBLIC LIMITED COMPANY
BIOVAIL CORPORATION
Decision Resources, Inc., June 2011
Trends: Rheumatoid Arthritis 2010, a report by BioTrends Research Group, a Decision Resources, Inc., company.
Dealmaking assessment: analysis of 46 deals featuring 71 unique companies/entities between 2005 and May
Wright Investors' Service, Feb 2012, Pages: 40
Limited versus AmylinPharmaceuticals, Inc., Elan Corporation PLC and Valeant Pharmaceuticals International. The comparative analysis of these companies compares Sales (sales, sales growth and sales per
Plimsoll Publishing Ltd., Feb 2012, Pages: 250
AMYLINPHARMACEUTICALSINC
DONG-A PHARMACEUTICAL CO.,LTD.
WOCKHARDT LIMITED
IMCLONE SYSTEMS INC
MILLENNIUM PHARMACEUTICALSINC
ELAN CORPORATION PUBLIC LIMITED COMPANY
INSTITUTO GRIFOLS SA
GREEN CROSS
NeuroInsights, May 2010
Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness
NeuroInsights, May 2011, Pages +: 500
Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global Neurological Disease and Psychiatric Illness
Plimsoll Publishing Ltd., Feb 2012, Pages: 200
SPA
TSUMURA & COMPANY
ZENTIVA N.V.
WARNER CHILCOTT LIMITED
CHINA PHARMACEUTICAL GROUP LIMITED
HUADONG MEDICINE CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES LIMITED
AMYLINPHARMACEUTICALSINC
YUNNAN BAIYAO